Abiopharma

🔍 Ingram Tamara (Director)

Company: MARSH & MCLENNAN COMPANIES, INC. (MRSH)

Report Date: 2026-08-14

Detailed Transactions and Holdings:

• Acquired 48 shares of Restricted Stk. Units-Dir. Stk. Plan (Derivative)
  Date: 2026-08-14 | Code: J | equity_swap_involved: 0 | shares_owned_after: 9,133.91 | transaction_form_type: 5 | Footnotes: F1, F2, F3, F3

Footnotes:

• F1: The security converts to Marsh & McLennan Companies common stock on a 1-for-1 basis.
• F2: Acquired with dividend equivalents credited to the reporting person's account under the Marsh & McLennan Companies Directors Stock Compensation Plan.
• F3: Not applicable.